Heart rhythm O2 · 2025
Pulmonary vein isolation and beyond: Feasibility and acute outcomes of the lattice-tip dual-energy catheter for complex ablations.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
My Ilaria, Nies Moritz, Moser Fabian, Lemoine Marc D, Rottner Laura, Govorov Katharina, Schenker Niklas, Zarfelder Alexander, Schoof Lauritz, Kirchhof Paulus, Reissmann Bruno, Ouyang Feifan, Metzner Andreas, Rillig Andreas
Аннотация
BACKGROUND: A new large-footprint catheter that switches between pulsed field ablation (PFA) and radiofrequency ablation (RFA) and integrates with a novel 3-dimensional (3D) mapping platform has been introduced.
OBJECTIVE: This study aimed to evaluate the safety, efficacy, and procedural characteristics of the large-footprint dual-energy catheter in patients undergoing catheter ablation for atrial fibrillation or atrial tachycardia.
METHODS: Consecutive patients undergoing left (LA) and right atrial ablation for atrial fibrillation or atrial tachycardias were analyzed. All patients were enrolled in the prospective TRUST Registry (NCT05521451).
RESULTS: 102 patients (37 women [36%]; median age 68 years [60-75]; median left ventricular ejection fraction 60% [53-60]) were included; 42 (41%) underwent first pulmonary vein isolation (PVI), and 57 (56%) repeat PVI. Median procedure and mapping times were 91 minutes (78-114) and 15 minutes (11.9-21.7), respectively; median 3D LA volume was 165 mL (142-199).In 75 patients (42 index, 33 repeat procedures), pulmonary veins were targeted, and first-pass isolation was achieved in all using PFA only (median ablation 25 minutes [16-34]). Additional LA lines were applied in 87 of 102 (85%): anterior (34, 25 of 34 [73%] PFA + RFA), mitral isthmus (27, 18 of 27 [67%] PFA + RFA; 5 of 27 [18%] with PFA in the coronary sinus), posterior box (45, PFA only), and roof (23, PFA only). All lines were bidirectionally blocked, and posterior boxes isolated. A cavotricuspid isthmus line was created in 36 of 102 (35%; 30 of 36 [83%] RFA only). Procedural complications occurred in 3 of 102 (2.9%).
CONCLUSION: The large-footprint dual-energy catheter enables safe and effective PVI, repeat PVI, and creation of complex left and right atrial lesion sets.
OBJECTIVE: This study aimed to evaluate the safety, efficacy, and procedural characteristics of the large-footprint dual-energy catheter in patients undergoing catheter ablation for atrial fibrillation or atrial tachycardia.
METHODS: Consecutive patients undergoing left (LA) and right atrial ablation for atrial fibrillation or atrial tachycardias were analyzed. All patients were enrolled in the prospective TRUST Registry (NCT05521451).
RESULTS: 102 patients (37 women [36%]; median age 68 years [60-75]; median left ventricular ejection fraction 60% [53-60]) were included; 42 (41%) underwent first pulmonary vein isolation (PVI), and 57 (56%) repeat PVI. Median procedure and mapping times were 91 minutes (78-114) and 15 minutes (11.9-21.7), respectively; median 3D LA volume was 165 mL (142-199).In 75 patients (42 index, 33 repeat procedures), pulmonary veins were targeted, and first-pass isolation was achieved in all using PFA only (median ablation 25 minutes [16-34]). Additional LA lines were applied in 87 of 102 (85%): anterior (34, 25 of 34 [73%] PFA + RFA), mitral isthmus (27, 18 of 27 [67%] PFA + RFA; 5 of 27 [18%] with PFA in the coronary sinus), posterior box (45, PFA only), and roof (23, PFA only). All lines were bidirectionally blocked, and posterior boxes isolated. A cavotricuspid isthmus line was created in 36 of 102 (35%; 30 of 36 [83%] RFA only). Procedural complications occurred in 3 of 102 (2.9%).
CONCLUSION: The large-footprint dual-energy catheter enables safe and effective PVI, repeat PVI, and creation of complex left and right atrial lesion sets.